Evidence map›Paper›PMID 37970338›Full record

ArticleAmerican journal of cancer research2023

Superiority of FAPI-PET/CT for examining multiple malignant tumors: a retrospective study.

Wei Li, Zhiyun Jiang, Nan Cui, Jiatong Li, Liang Cheng, Wei Liu, Jing Li, Kezheng Wang

Erratum issuedOpen access · bronzeAbstract read
PubMed Full text at PMC
In one paragraph

Article in American journal of cancer research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact, top 100% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Evaluating the diagnostic value ofJapanese journal of radiology · 2025
    Article
  5. Clinical significance of diffuse [EJNMMI research · 2025
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Wei LiDepartment of PET-CT/MRI, Harbin Medical University, Harbin Medical University Cancer Hospital Harbin 150081, Heilongjiang, China.
Zhiyun JiangDepartment of PET-CT/MRI, Harbin Medical University, Harbin Medical University Cancer Hospital Harbin 150081, Heilongjiang, China.
Nan CuiDepartment of PET-CT/MRI, Harbin Medical University, Harbin Medical University Cancer Hospital Harbin 150081, Heilongjiang, China.
Jiatong LiDepartment of PET-CT/MRI, Harbin Medical University, Harbin Medical University Cancer Hospital Harbin 150081, Heilongjiang, China.
Liang ChengDepartment of PET-CT/MRI, Harbin Medical University, Harbin Medical University Cancer Hospital Harbin 150081, Heilongjiang, China.
Wei LiuDepartment of PET-CT/MRI, Harbin Medical University, Harbin Medical University Cancer Hospital Harbin 150081, Heilongjiang, China.
Jing LiDepartment of PET-CT/MRI, Harbin Medical University, Harbin Medical University Cancer Hospital Harbin 150081, Heilongjiang, China.
Kezheng WangDepartment of PET-CT/MRI, Harbin Medical University, Harbin Medical University Cancer Hospital Harbin 150081, Heilongjiang, China.
Harbin Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To compare the diagnostic value of [

Indexed as

[18F]-AlF-NOTA-FAPI-04 PET/CT[18F]-FDG PET/CTbone and visceral metastasislymph node metastasisperitoneal metastasis

Identifiers

PMID37970338
PMCPMC10636689
OpenAlexW4388737013

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.